These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18513266)

  • 1. Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization.
    Kurup S; Lew J; Byrnes G; Yeh S; Nussenblatt R; Levy-Clarke G
    Acta Ophthalmol; 2009 May; 87(3):349-52. PubMed ID: 18513266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab for uveitic choroidal neovascularization.
    Doctor PP; Bhat P; Sayed R; Foster CS
    Ocul Immunol Inflamm; 2009; 17(2):118-26. PubMed ID: 19412874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.
    Tran TH; Fardeau C; Terrada C; Ducos De Lahitte G; Bodaghi B; Lehoang P
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1685-92. PubMed ID: 18682970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
    Batioğlu F; Astam N; Ozmert E
    Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal injection of bevacizumab in Eales disease.
    Küçükerdönmez C; Akova YA; Yilmaz G
    Ocul Immunol Inflamm; 2008; 16(1):63-5. PubMed ID: 18379947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab for iris neovascularization following proton beam irradiation for choroidal melanoma.
    Yeung SN; Paton KE; Waite C; Maberley DA
    Can J Ophthalmol; 2010 Jun; 45(3):269-73. PubMed ID: 20379286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab for choroidal neovascularization related to inflammatory diseases.
    Kramer M; Axer-Siegel R; Jaouni T; Reich E; Hemo I; Priel E; Averbukh E; Ehrlich R; Chowers I; Weinberger D; Amer R
    Retina; 2010 Jun; 30(6):938-44. PubMed ID: 20168273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravitreal bevacizumab in neovascularisation secondary to age-related macular degeneration].
    Ordóñez Fernández L; Celemín Viñuela ML; Fernández Lisa C; García Alonso A; Fonolla Gil M; Fernández Bustillo E
    Farm Hosp; 2008; 32(1):53-4. PubMed ID: 18426702
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
    Jonas JB; Libondi T; Schlichtenbrede F; Schmidbauer M
    Acta Ophthalmol; 2010 Mar; 88(2):e24-5. PubMed ID: 19493250
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months.
    Arevalo JF; Adan A; Berrocal MH; Espinoza JV; Maia M; Wu L; Roca JA; Quiroz-Mercado H; Ruiz-Moreno JM; Serrano MA;
    Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for myopic choroidal neovascularization.
    Rensch F; Spandau UH; Schlichtenbrede F; von Baltz S; Libondi T; Jonas JB; Vossmerbaeumer U
    Ophthalmic Surg Lasers Imaging; 2008; 39(3):182-5. PubMed ID: 18556936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab (avastin) for subfoveal neovascular age-related macular degeneration.
    Levy J; Shneck M; Rosen S; Klemperer I; Rand D; Weinstein O; Pitchkhadze A; Belfair N; Lifshitz T
    Int Ophthalmol; 2009 Oct; 29(5):349-57. PubMed ID: 18545937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy.
    Kernt M; Gschwendtner A; Neubauer AS; Dichgans M; Haritoglou C
    J Neurol; 2010 Jul; 257(7):1213-4. PubMed ID: 20179959
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
    Bae JH; Lee CS; Lee SC
    Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for idiopathic choroidal neovascularization.
    Cakir M; Cekiç O; Yilmaz OF
    J AAPOS; 2009 Jun; 13(3):296-8. PubMed ID: 19285890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid regression of retinal hemorrhage and neovascularization in a case of familial exudative vitreoretinopathy treated with intravitreal bevacizumab.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1787-9. PubMed ID: 18795314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study.
    Mackensen F; Heinz C; Becker MD; Heiligenhaus A
    Retina; 2008 Jan; 28(1):41-5. PubMed ID: 18185136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab as first local treatment for uveitis-related choroidal neovascularization: long-term results.
    Julián K; Terrada C; Fardeau C; Cassoux N; Français C; LeHoang P; Bodaghi B
    Acta Ophthalmol; 2011 Mar; 89(2):179-84. PubMed ID: 21348964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.